Rosenbaum, Marsha 280–1
Rosenhan, David 331, 332
Ross, Stephen 256, 260
Rowell Laboratories 105
Rufus of Ephesus 207, 208
Sabbagh, Karl 211
Sackheim, Harold 311
Sacktor, Todd 292, 294, 295–6, 297, 298
Sakel, Manfred 12, 13
Salzman, Carl 153
Sassyfras 280
Schacter, Daniel 299
Schildkraut, Joseph 157–8
schizophrenia 11, 18, 129–30
anatomic theories of 52
chlorpromazine therapy see chlorpromazine
deep sleep therapy 14
dopamine hypothesis 52, 53, 176, 191, 328
double-bind theory of 49
incidence of 54
insulin coma therapy 13
lithium therapy 80, 83, 110
LSD therapy 275
pentylenetetrazol therapy 13–14
psychosurgery 15–16
Schmidlin, Paul 130
Schou, Mogens 86, 87, 88, 91–2, 95, 98, 99–104, 105, 110
self-harming 118, 120, 179, 335
Senning, Åke 325
serotonin 17, 50–1, 54, 139, 142, 144, 145, 157, 158, 161–2, 172, 175, 191, 194
low-serotonin hypothesis 144–5, 148, 328, 330
sertraline 85, 171
7UP soft drink 63
sex addicts 180–1
Sexton, Anne 93
sexual dysfunction 174–6, 180–3
Shadyac, Tom 167
sham acupuncture 231–2
sham surgery 219–23
shamanic traditions 242–3, 265, 339, 342
Shapiro, Arthur and Elaine 214
Shepherd, Michael 100–1, 102, 103, 104, 105
Shorter, Edward 199
Shriver, Lionel 185
Shuge, Kelly and Thomas 269–71, 278
Shulgin, Alexander 272
Shulgin, Ann 272
Sigwald, Jean 34
Smith, Gwenn 303
Smith, Huston 254–5, 261
Smith, Kline & French 39, 40, 41, 45, 47, 48, 105
smoking addiction 264
SNRIs (serotonin and noradrenaline reuptake inhibitors) 178, 334
social anxiety 5, 173, 274
spas and springs 64–5
spectrophotofluorometer 50, 51
spectrophotometer 88, 99
Spitzer, Robert 332
spontaneous remission 79
SSRIs (selective serotonin reuptake inhibitors) 4–5, 85, 93, 157–209, 314, 341–2
author’s experience of 178–9, 202–4, 334
earliest 157–9
efficacy, limits on 319, 342
long- and mid-term studies on 171–2
numbing effects 177, 178, 184, 200
rising doses 202–3
and sexual dysfunction 174–6, 180–3
side effects 171, 172, 174–6, 177, 178, 181–2, 184, 200, 203, 342
tolerance problem 334
withdrawal effects 201, 204
see also specific index entries
statins 54
Strömgren, Erik 86, 110
suicide and suicidal feelings 148, 165–6, 167, 185, 230, 311, 317, 336, 338
sulphonamides 67
sumatriptan 217
summer blue 125, 127
surgical shock 23–4
synaptic cleft 145, 158, 172, 191, 194
Szasz, Thomas 54, 56, 57, 193
talking therapies 6, 17, 40, 223–8, 339
see also cognitive behavioural therapy (CBT);
psychoanalysis; psychotherapy
tardive dyskinesia 48, 54, 154
Teicher, Martin 185
thiopental 29
Thompson, J. Anderson 181, 183, 184
Thorazine 12, 18, 25, 40
see also chlorpromazine
Thuillier, Jean 38
Tofranil 139
see also imipramine
trans-cranial magnetic stimulation (TMS) 222
transmyocardial laser revascularisation (TMR) 220–1
tranylcypromine 149
traumatic memories 290–3, 297, 298
see also post-traumatic stress disorder
tricyclics 124, 125, 127, 140, 145, 150, 151, 157, 160, 197, 200–1, 330, 334
side effects 146
see also imipramine
Trivers, Robert 218
turpentine injections 15
tyramine 146, 150
unipolar disorder 76
United States
antipsychotic use 54
incidence of depression in 162–3
mental hospitals 12
Ure, Alexander 64
urea, synthesising of 124–5
uric acid 62–4, 65, 66, 67, 68–9, 72
Utena, Hiroshi 57
vagus nerve stimulation (VNS) 222
Val-de-Grâce military hospital 22, 23, 28, 29–31
Valenstein, Elliot 12
Valium 197
valproate 111
valproate semisodium 111, 126
Velez, Maria Eugenia 294–5
venlafaxine 3, 171, 178, 203, 285, 334
veratrine 16
Vincent, Carol 237–8, 261, 262–3, 264, 266
voodoo death 228–9
Vuckovic, Alexander 55, 111, 113
Waldron, A.M. 98
Wallace, David Foster 146–8
Wasson, R. Gordon 241–3
Wesbecker, Joseph 186–7, 189
West, Louis Jolyon 309
Whitaker, Robert 190, 191–2, 193, 195, 334
Wiesel, Elie 299
Winfrey, Oprah 282
Wöhler, Friedrich 124–5
Wong, David T. 159
Yin, Jerry 294
Young, R.M. 83, 86, 99
Zeff, Leo 272
Zelmid 158
zimelidine 158, 159
ZIP (zeta inhibitory peptide) 296–8, 299–302
ziprasidone 53
Zyprexa 79, 95, 96
First published in the United States by Little, Brown and Company, 2018
First published in Great Britain by Simon & Schuster UK Ltd, 2018
A CBS COMPANY
Copyright © Lauren Slater, 2018
The right of Lauren Slater to be identified as the author of this work has been asserted in accordance with the Copyright, Designs and Patents Act, 1988.
Simon & Schuster UK Ltd
1st Floor
222 Gray’s Inn Road
London WC1X 8HB
www.simonandschuster.co.uk
www.simonandschuster.com.au
www.simonandschuster.co.in
Simon & Schuster Australia, Sydney
Simon & Schuster India, New Delhi
The author and publishers have made all reasonable efforts to contact copyright-holders for permission, and apologise for any omissions or errors in the form of credits given. Corrections may be made to future printings.
A CIP catalogue record for this book is available from the British Library
Hardback ISBN: 978-1-4711-3688-7
Trade Paperback ISBN: 978-1-4711-3689-4
eBook ISBN: 978-1-4711-3691-7
Typeset in the UK by M Rules
Printed and bound by CPI Group (UK) Ltd, Croydon, CR0 4YY
Simon & Schuster UK Ltd are committed to sourcing paper that is made from wood grown in sustainable forests and support the Forest Stewardship Council, the leading international forest certification organisation. Our books displaying the FSC logo are printed on FSC certified paper.
ass="sharethis-inline-share-buttons">share
The Drugs That Changed Our Minds Page 44